Johnson & Johnson Launches the First and Only Daily Disposable Multifocal Toric Contact Lens[1] for Astigmatic Adults living with Presbyopia

by | PRNewswire Asia

The brand also expands daily disposable options for astigmatic adults with the launch of ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, bringing pioneering innovation that delivers visual clarity and comfort [+],[**],[2],[3] as vision needs evolve. SINGAPORE, Feb....

AIA RESEARCH REVEALS INGRAINED HEALTH STEREOTYPES ARE HOLDING BACK WELLBEING IN ASIA

by | PRNewswire Asia

HONG KONG, Feb. 9, 2026 /PRNewswire/ — AIA Group Limited ("AIA" or the "Group") today releases new research revealing that deeply entrenched physical, mental and financial health stereotypes shape attitudes and behaviours around wellbeing...

Peijia Medical Submits EU MDR CE Mark Registration Application for GeminiOne® TEER System

by | PRNewswire Asia

HONG KONG, Feb. 9, 2026 /PRNewswire/ — Peijia Medical Limited (HKEX: 9996) today announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration application for its internally developed GeminiOne Transcatheter...

Village Grocer Expands its Footprint to Damansara with New Store Opening at Hextar World, Empire City

by | PRNewswire Asia

PETALING JAYA, Malaysia, Feb. 7, 2026 /PRNewswire/ — Village Grocer, Malaysia’s leading premium supermarket chain, officially opens its doors today at the highly anticipated Hextar World @ Empire City. This new outlet marks a significant milestone in the...

Angel Yeast Indonesia Project: Strengthening Foundations through Technical Training and Building Consensus through Cultural Exchange

by | PRNewswire Asia

YICHANG, China, Feb. 6, 2026 /PRNewswire/ — Angel Yeast Group (SH600298) recently welcomed 29 employees from Indonesia to its headquarters in Yichang, China, for a six-month structured training program. The initiative is designed to develop a cohort of...

LT3001 DEMONSTRATES FUNCTIONAL IMPROVEMENTS IN PATIENTS WITH DISABLING ACUTE ISCHEMIC STROKE

by | PRNewswire Asia

Breakthrough Phase 2 Trial Results Show Promise for Patients Ineligible for Standard Reperfusion Therapies Data Presented at International Stroke Conference Data Show That LT3001 Delivers Meaningful Functional Improvements in Patients Suffering from Disabling Acute...